NEWS IN BRIEF

Ardena: M&A growth fuels HQ expansion

By Flora Southey contact

- Last updated on GMT

Ardena HQ, Belgium
Ardena HQ, Belgium

Related tags: CDMO, Belgium

CDMO Ardena has moved into larger headquarters in Gent, Belgium, to “free up space for additional laboratories”, says CEO.

According to the contract development and manufacturing organisation (CDMO), a sustained period of growth, driven by mergers and acquisitions, prompted the move.

“After several acquisitions and an ongoing growth period, we are firmly on track to reach our €35m ($39.7m) sales target for 2018 ​as part of our wider strategy to become a leading integrated drug development company,”​ said CEO Harry Christiaens.

Ardena was formed in 2017, as the result of a merger between Pharmavize, Crystallics and Analytical Biochemical Laboratory (ABL).

The CDMO has since integrated active pharmaceutical ingredient (API) and nanomedicine maker, ChemConnection​, as well as API and excipient-focused Syntagon​ into its business.

Christiaens continued: “This new, larger headquarters will enable us to free up space for additional laboratories at our other sites and further expand our capabilities.

“It will also provide a base for our staff training centre to ensure we develop our team.”

Related news

Show more

Follow us

Products

View more

Webinars